Speakers
- David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company & President of IFPMA
- Daniel O’Day, Chairman of the Board of Directors and Chief Executive Officer, Gilead
- Kenneth C. Frazier, Chairman of the Board and Chief Executive Officer, MSD
- Dr Albert Bourla, Chairman and Chief Executive Officer, Pfizer
- Dr Severin Schwan, Chief Executive Officer, Roche & Vice-President IFPMA
- Thomas Cueni, Director General, IFPMA
- Moderated by Claire Doole
Followed by 45 mins Q&A; written questions provided in advance will be handled first, followed by as many questions as can be handled from the CHAT.
(provide your full name and media outlet)
For follow up: please contact a.jones@ifpma.org
